Advanced search
Publication Cover
Brain Injury Volume 34, 2020 - Issue 10
Submit an article Journal homepage
273
Views
7
CrossRef citations to date
0
Altmetric
Case Report

Use of CGRP receptor blocker erenumab in the management of post-traumatic headache: a case series of 5 women

Jordan VanderEndeDepartment of Physical Medicine & Rehabilitation, Western University, London, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6463-7145View further author information
ORCID Icon,
Emma A. BatemanDepartment of Physical Medicine & Rehabilitation, Western University, London, CanadaView further author information
,
Heather M. MacKenzieDepartment of Physical Medicine & Rehabilitation, Western University, London, CanadaView further author information
&
Keith SequeiraDepartment of Physical Medicine & Rehabilitation, Western University, London, CanadaView further author information
Pages 1431-1434 | Received 29 Sep 2019, Accepted 04 Aug 2020, Published online: 13 Aug 2020

References

  • Lucas S. Posttraumatic headache: clinical characterization and management. Curr Pain Headache Rep. 2015 Oct;19(10):48. doi:10.1007/s11916-015-0520-1.
  • Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA. 2008 Aug 13;300(6):711–19. doi: 10.1001/jama.300.6.711.
  • Lucas S. Headache management in concussion and mild traumatic brain injury. PMR. 2011;3(10 suppl 2):S406–412. doi:10.1016/j.pmrj.2011.07.016.
  • Hepp Z, Bloudek LM, Varon SF. Systematic review of migraine prophylaxis adherence and persistence. J Manag Care Pharm. 2014 Jan;20(1):22–33. doi:10.18553/jmcp.2014.20.1.22.
  • He A, Song D, Zhang L, Li C. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis. J Headache Pain. 2017 Dec;18(1):26. doi:10.1186/s10194-017-0720-7.
  • Plantier D, Luauté J, SOFMER group. Drugs for behavior disorders after traumatic brain injury: systematic review and expert consensus leading to French recommendations for good practice. Ann Phys Rehabil Med. 2016 Feb;59(1):42–57. doi:10.1016/j.rehab.2015.10.003.
  • Kobeissy FH, editor. Brain neurotrauma: molecular, neuropsychological and rehabilitation aspects. Boca Rotan (FL): CRC Press/Taylor & Francis; 2015. p. 725.
  • Marshall S, Bayley M, McCullagh S, Berrigan L, Fisher L, Ouchterlony D, Rockwell C, Velikonja D, et al. Guidelines for concussion/mild traumatic brain injury and persistent symptoms (for adults 18+ years of age). 3rd ed. Toronto (ONT): Ontario Neurotrauma Foundation; 2018.
  • Conidi FX. Interventional treatment for post-traumatic headache. Curr Pain Headache Rep. 2016 Jun;20(6):40. doi:10.1007/s11916-016-0570-z.
  • Defrin R. Chronic post-traumatic headache: clinical findings and possible mechanisms. J Man Manip Ther. 2014 Feb;22(1):36–44. doi:10.1179/2042618613Y.0000000053.
  • Edvinsson L. The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine. Headache. 2017 May;57(Suppl 2):47–55. doi:10.1111/head.13081.
  • Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013 Dec;154(Suppl 1):S44–53. doi:10.1016/j.pain.2013.07.021.
  • Goadsby PJ, Reuter U, Hallström Y, Broessner G, Bonner JH, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017 Nov 30;377(22):2123–32. doi: 10.1056/NEJMoa1705848.
  • Tepper S, Ashina M, Reuter U, Brandes JL, Doležil D, Silberstein S, Winner P, Leonardi D, Mikol D, Lenz R. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2017 Jun;16(6):425–34. doi:10.1016/S1474-4422(17)30083-2.
  • Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, CARE Group. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014 Jan;67(1):46–51. doi:10.1016/j.jclinepi.2013.08.003.
  • Thompson JM. Persistent symptoms following mild traumatic brain injury (mTBI) – a resource of clinicians and staff. Veteran Affairs Canada Research Directorate Technical Report. 2008 Sept: 26.
  • Russo AF. Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol. 2015;55(1):533–52. doi:10.1146/annurev-pharmtox-010814-124701.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.